Veterinary and Comparative Oncology

International Veterinary Cancer

Treatment of vascular and soft-tissue sarcomas in dogs using an alternating protocol of ifosfamide and doxorubicin
pp. 171-179(9)
Authors: Payne S.E.; Rassnick K.M.; Northrup N.C.; Kristal O.; Chretin J.D.; Cotter S.M.; Kintzer P.; Frimberger A.E.; Morrison-Collister K.E.; Wood C.A.; Moore A.S.

A combination chemotherapy protocol with MOPP and CCNU consolidation (Tufts VELCAP-SC) for the treatment of canine lymphoma
pp. 180-190(11)
Authors: Morrison-Collister K.E.; Rassnick K.M.; Northrup N.C.; Kristal O.; Chretin J.D.; Williams L.E.; Cotter S.M.; Moore A.S.

Treatment of unresectable hepatocellular adenoma in dogs with transarterial iodized oil and chemotherapy with and without an embolic agent: A report of two cases
pp. 191-199(9)
Authors: Cave T.A.; Johnson V.; Beths T.; Edwards R.; Argyle D.J.

Breed incidence of lymphoma in a UK population of insured dogs
pp. 200-206(7)
Authors: Edwards D.S.; Henley W.E.; Harding E.F.; Dobson J.M.; Wood J.L.N.

The bisphosphonates alendronate and zoledronate are inhibitors of canine and human osteosarcoma cell growth in vitro
pp. 207-215(9)
Authors: Poirier V.J.; Huelsmeyer M.K.; Kurzman I.D.; Thamm D.H.; Vail D.M.

Influence of honey bee products on transplantable murine tumours
pp. 216-226(11)
Authors: Oroli N.; Knezevi A.; ver L.; Terzi S.; Hackenberger B.K.; Bai I.

Hypertrophic osteopathy secondary to pulmonary sarcoma in a cat
pp. 227-231(5)
Authors: Grierson J.M.; Burton C.A.; Brearley M.J.

Ocular metastasis of a vaccine-associated fibrosarcoma in a cat
pp. 232-240(9)
Authors: Cohen M.; Sartin E.A.; Whitley E.M.; Whitley R.D.; Smith A.N.; Brawner W.R.; Henderson R.; Behrend E.N.